Summary
The effect of clonidine on gastric acid secretion was investigated using rats and dogs. In the stomach lumen perfused rat basal gastric acid secretion was increased by clonidine in the anaesthetized rat but inhibited in the conscious animal. Clonidine also reduced the basal gastric acid secretion in rats with chronic gastric fistula, (ED50 12 μg/kg p.o.). In addition, gastric secretion stimulated by insulin hypoglycaemia was inhibited by clonidine in anaesthetized stomach lumen perfused rats and in conscious dogs with gastric fistula. In the rat gastric secretion stimulated by electrical vagus stimulation was inhibited as well. However, clonidine had no effect on the gastric acid secretion stimulated by carbachol in stomach lumen perfused rats and in dogs with denervated fundic pouch.
These results suggest that the inhibition of gastric acid secretion by clonidine probably is due to an inhibition of acetylcholine release at the vagus nerve endings. Additional central gastric antisecretory effects can, however, not be excluded by this study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bachrach, W. H.: Action of insulin hypoglycaemia on motor and secretory functions of the digestive tract. Physiol. Rev. 33, 566–592 (1953)
Boissier, J. R., Giudicelli, J. F., Larno, S., Fichelle, J.: Action de la clonidine (St-155) sur la secretion gastrique et l'ulcere experimental. J. Pharmacol. (Paris) 1, 109–122 (1970)
Borella, L. E., Herr, F.: A new method for measuring gastric acid secretion in unanaesthetized rats. Gastroenterology 61, 345–356 (1971)
Brodie, D. A., Marshall, R. W., Moreno, O. M.: Effect of restraint on gastric acidity in the rat. Amer. J. Physiol. 202, 812–814 (1962)
Curwain, B. P., Endersby, K.: Enhancement of pentagastrin-induced gastric acid secretion by clonidine in the conscious dog. Brit. J. Pharmacol. 50, 431–434 (1974)
Deck, R., Oberdorf, A., Kroneberg, G.: Die Wirkung von 2-(2,6-Dichlorphenylamino) 1-2-imidazolin-Hydrochlorid (Clonidin) auf die Kontraktion und die Acetylcholin-Freisetzung an isolierten, koaxial elektrisch gereizten Meerschweinchenileum. Arzneimittel-Forsch. 21, 1580–1584 (1971)
Hantschmann, N.: Einfluß der Urethan-Narkose auf eine durch Insulin induzierte Hypoglykaemie und die vagale Säuresekretion bei der Ratte. Arzneimittel-Forsch. 22, 1984–1988 (1972)
Hedeland, H., Dymling, J. F., Hoekfelt, B.: Pharmacological inhibition of adrenalin secretion following insulin induced hypoglycaemia in man: the effect of catapresan. Acta endocr. (Kbh.) 67, 97–103 (1971)
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorids, einer neuen antihypertensiven Substanz. Arzneimittel-Forsch. 16, 1038–1050 (1966)
Karppanen, H. O., Westermann, E.: Increased production of cyclic AMP in gastric tissue by stimulation of histamine 2 (H2)-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol 279, 83–87 (1973)
Kim, K. S., Shore, P. A.: Mechanism of action of reserpine and insulin on gastric amines and gastric acid secretion, and the effect of monoamine oxidase inhibition. J. Pharmacol. exp. Ther. 141, 321–325 (1963)
Lai, K. S.: Studies on gastrin. Part I. A method of biological assay of gastrin. Gut 5, 327–333 (1964)
Levine, R. J.: Stimulation by saliva of gastric acid secretion in the rat. Life Sci. 4, 959–964 (1965)
Neuhaus, G. A., Humpert, U.: Die Beeinflussung der gesteigerten Magensaftsekretion unter intramuskulärer Gabe von 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorid. In: Hochdrucktherapie (L. Heilmeyer, H. J. Holtmeier, E. F. Pfeiffer, eds.), pp. 205–210. Stuttgart: Thieme 1968
Ottenjann, R.: Sekretion, Motilität und Schleimhautdurchblutung des Magens unter dem Einfluß von Dichlorphenylaminoimidazolin. In: Hochdrucktherapie (L. Heilmeyer, H. J. Holtmeier, E. F. Pfeiffer, eds.), pp. 202–205. Stuttgart: Thieme 1968
Pettinger, W. A.: Clonidine, a new antihypertensive drug. New Engl. J. Med. 293, 1179–1180 (1975)
Rand, M. J., Rush, M., Wilson, J.: Some observations on the inhibition of salivation by St-155 (2-(2,6-Dichlorphenylamine)-2-imidazoline hydrochloride, catapres, catapresan). Europ. J. Pharmacol. 5, 168–172 (1969)
Schmitt, H., Schmitt, H.: Localization of the hypotensive effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St-155, catapresan). Europ. J. Pharmacol. 6, 8–12 (1969)
Stockhaus, K., Wick, H.: Die Beeinflussung der Magensaftsekretion durch den Speichel von Ratten mit Pylorus-Unterbindung (Shay-Ratte). Arzneimittel-Forsch. 20, 858–861 (1970)
Walz, A., van Zwieten, P. A.: The influence of 2-(2,6-Dichlorphenylamino)-2-imidazoline hydrochloride (Clonidine) and some related compounds on gastric secretion in the anaesthetized rat. Europ. J. Pharmacol. 10, 369–377 (1970)
Werner, K., Starke, K., Schümann, H. J.: Actions of clonidine and 2-(2-methyl-6-ethyl-cyclohexylamino)-2-oxazoline on postganglionic autonomic nerves. Arch. int. Pharmacodyn. 195, 282–290 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jennewein, H.M. The effect of clonidine on gastric acid secretion in rats and dogs. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, 85–90 (1977). https://doi.org/10.1007/BF00508814
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00508814